Linked Life Data

18519780

Source:http://linkedlifedata.com/resource/pubmed/id/18519780

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2008-6-3
pubmed:abstractText
To determine the toxicity, tolerability, pharmacokinetics, pharmacodynamics, and preliminary antitumor activity of oral gemcitabine (2',2'-difluorodeoxycytidine; dFdC) in patients with cancer.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1078-0432
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3477-86
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Oral administration of gemcitabine in patients with refractory tumors: a clinical and pharmacologic study.
pubmed:affiliation
Division of Experimental Therapy, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands. s.veltkamp@nki.nl
pubmed:publicationType
Journal Article, Clinical Trial, Phase I